Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Signet Closes Fourth Life Science Fund at $137 Million

Posted in Life Sciences Investing

Signet Healthcare Partners has announced it has closed its fourth life science fund, Signet Healthcare Partners IV L.P., with $137.2 million of capital commitments.

Signet, based in New York and founded in 1998, is a private equity fund that focuses on investments in commercial-stage healthcare companies, specifically pharmaceutical sector and medical technology companies.

Through Signet Healthcare Partners IV, the firm indicated it intends to invest in 10-12 companies and will typically invest $10-15 million per company.

We use cookies to enhance your experience of our website. By continuing to use this website, you agree to the use of these cookies. For more information and to learn how you can change your cookie settings, please see our policy.

Agree